Tredje Ap Fonden Exact Sciences Corp Transaction History
Tredje Ap Fonden
- $10.8 Billion
- Q3 2024
A detailed history of Tredje Ap Fonden transactions in Exact Sciences Corp stock. As of the latest transaction made, Tredje Ap Fonden holds 28,160 shares of EXAS stock, worth $1.59 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
28,160
Previous 28,160
-0.0%
Holding current value
$1.59 Million
Previous $1.19 Million
61.23%
% of portfolio
0.02%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding EXAS
# of Institutions
673Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$895 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$810 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$682 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$377 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...